FDABridge
← ব্লগে ফিরে যান
সাধারণ

FDA 이야기 #016 — 이집트 대추야자 수출업체의 Prior Notice에 잘못된 FDA 등록 번호가 있었다

제품이 '에너지 증진 및 면역 기능 지원'을 주장했습니다. 이는 구조/기능 주장입니다. 제품에는 Nutrition Facts가 아닌 Supplement Facts 패널이 필요했습니다.

FDABridge দল১ জানু, ২০২৬2 মিনিট পড়ুন

A matcha company in Uji, Kyoto, produced a premium ceremonial-grade matcha powder that they sold in Japan as a traditional tea. When they expanded to the US, their American distributor suggested adding health claims to the marketing: 'Boosts energy naturally,' 'Supports immune function,' 'Rich in antioxidants for cellular health.'

The product was labeled as a food with a Nutrition Facts panel. The marketing materials — on the website, on Amazon, and on shelf talkers — contained structure/function claims.

문제

Under US law, a product that makes structure/function claims — claims about how a substance affects the structure or function of the body — is either a dietary supplement (if it contains a dietary ingredient and is intended for ingestion) or a drug (if the claims go further into disease treatment). A conventional food cannot make structure/function claims without triggering reclassification. 'Boosts energy' and 'supports immune function' are structure/function claims that pushed the matcha from the food category into the dietary supplement category.

As a dietary supplement, the product needed a Supplement Facts panel (not Nutrition Facts), the required disclaimer ('This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease'), a structure/function claim notification filed with the FDA within 30 days of first marketing, and facility registration under the dietary supplement CGMP requirements of 21 CFR Part 111.

해결

The company had two paths. They could remove all structure/function claims and sell the matcha as a conventional food — which would require only the standard food facility registration and a Nutrition Facts panel. Or they could keep the claims and comply with dietary supplement regulations. They chose to sell the matcha as a conventional food in retail stores (no health claims) and as a dietary supplement through their e-commerce channel (with compliant claims and labeling). Two SKUs. Two labels. Two regulatory pathways from the same facility.

If your product is a tea, powder, extract, or botanical and you want to make health-related claims in the US — you are almost certainly selling a dietary supplement, not a food. The labeling, registration, and compliance requirements are different. Get it right before you launch. fdabridge.com/contact.

পরবর্তীতে সাহায্য দরকার?

সেবা নির্বাচনে সাহায্য দরকার?

প্রধান বিকল্পগুলি তুলনা করুন এবং আপনার পণ্যের জন্য সঠিক প্রক্রিয়া বেছে নিন।

আরও পড়ুন

সম্পর্কিত নিবন্ধ

সাধারণ

의료기기 라벨링 기호: 미국 시장 진입을 위해 해외 제조업체가 알아야 할 사항

২৮ এপ্রি, ২০২৬

미국의 의료기기 라벨링에는 적절한 통신을 위해 특정 기호가 필요합니다. 해외 제조업체는 미국 시장에 기기를 수출하기 전에 FDA가 수용하는 기호 기준을 이해해야 합니다.

আরও পড়ুন →
সাধারণ

해외 제조업체를 위한 의료기기 등록: 미국 규제 시스템 가이드

২৬ মার্চ, ২০২৬

해외 의료기기 제조업체는 사업소를 등록하고, 기기를 목록에 등록하며 — 기기 등급에 따라 — 미국에서 유통하기 전에 FDA 허가 또는 승인을 받아야 합니다.

আরও পড়ুন →
সাধারণ

FDA 상담자 를 고용 하기 전 에 질문 할 수 있는 10 가지 질문

২৪ মে, ২০২৬

FDA의 준수 서비스 제공자를 선택하는 것은 중요한 결정입니다. 이 10가지 질문은 외국 제조업체가 능력 있는 컨설턴트를 해결할 수 없는 문제들을 만들어내는 사람들로부터 분리시키는 데 도움이 됩니다.

আরও পড়ুন →